Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial
作者： Yufei Liu , Luyang Yao , Neda Kalhor , Brett W Carter , Mehmet Altan
DOI:
关键词:
摘要: … On this post-hoc final efficacy analysis of the DETERRED trial … , a subset analysis of patients with EGFR mutations in the … PACIFIC trial: Durvalumab after chemoradiotherapy in stage …
参考文章(0)